. (2022). Morbidities among older workers and work exit: the HEAF cohort. Occup Med (Lond). http://doi.org/10.1093/occmed/kqac068
C. Cooper
First name
C.
Last name
Cooper
. (2022). Estimating the incidence and key risk factors of cardiovascular disease in patients at high risk of imminent fracture using routinely collected real-world data from the UK. J Bone Miner Res. http://doi.org/10.1002/jbmr.4648
. (2022). Comparative risk of acute myocardial infarction for anti-osteoporosis drugs in primary care: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database. Osteoporos Int. http://doi.org/10.1007/s00198-021-06262-1
. (1998). Use of cyclical etidronate and prevention of non-vertebral fractures. Br J Rheumatol.
. (1997). Upper gastrointestinal adverse events and cyclical etidronate. Am J Med.
. (1998). Postmarketing surveillance of the safety of cyclic etidronate. Pharmacotherapy.
. (2000). Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford).
. (2000). The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/1099-1557(200009/10)9:5<359::aid-pds507>3.0.co;2-e
. (2000). Use of nonsteroidal anti-inflammatory drugs and risk of fractures. Bone.
. (2000). Use of oral corticosteroids and risk of fractures. J Bone Miner Res. http://doi.org/10.1359/jbmr.2000.15.6.993